• Working with

    passion, integrity,
    & true innovation

  • Developing

    novel, first-in-class therapeutics

  • Targeting

    major unmet medical needs

  • Changing

    the approach to
    treating cancer

Imetelstat

First-in-class, first-in-clinic,
telomerase inhibitor

 

Telomerase

Learn about our innovative approach to developing a treatment for cancer

 

Distribution of
Asterias Series A
Common Stock

Click here for important information

 

Geron News

6.12.2014

Geron Reports Removal of Partial Clinical Hold on Myelofibrosis IST

Read More

5.28.2014

Geron to Present at the Jefferies Healthcare Conference

Read More

5.9.2014

Geron Announces Record Date for Distribution of Asterias Series A Common Stock

Read More

 

Events

6.4.2014

Geron at the Jefferies Healthcare Conference

Listen to Webcast

Download Slides

5.20.2014

Geron 2014 Annual Meeting of Stockholders

Learn more

5.15.2014

Geron at the Bank of America Merrill Lynch Health Care Conference

Listen to Webcast

Download Slides